Update on tocolytic therapy in the management of preterm labor.
D000318:Adrenergic beta-Agonists / Q000009:adverse effects / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D008278:Magnesium Sulfate / Q000009:adverse effects / Q000627:therapeutic use; D007752:Obstetric Labor, Premature / Q000517:prevention & control*; D011247:Pregnancy; D011448:Prostaglandin Antagonists / Q000009:adverse effects / Q000627:therapeutic use
D000318:Adrenergic beta-Agonists; D002121:Calcium Channel Blockers; D011448:Prostaglandin Antagonists; D008278:Magnesium Sulfate